All News

GADIS was first launched in December 2011 to connect practicing DI specialists to each other and promote information sharing among pharmacists.

Officials with the FDA have approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.

Officials with the FDA have approved a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film (Cassipa, Teva Pharmaceuticals) for the maintenance treatment of opioid dependence.

Presenters delved into the topic of biological drugs and gene therapy during the recent International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland.

Two speakers faced off during a session at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, Scotland, about whether these products have merit.

The new formulation is the only immune globulin available in the United States that is approved for post-exposure protection against hepatitis A and measles.

The role of pharmacists in these causes and natural disasters continues to evolve as organizers and policymakers understand the value that they bring to these events.

Although statins have been linked to benefits among older patients with cardiovascular disease, the results of a recent study indicate that there is insufficient evidence to recommend the drug class’ widespread use in healthy adults over the age of 75.

Ozanimod reduced the number of brain lesions and lowered relapse rates in patients with relapsing multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the FDA have approved riluzole (Tigultik, ITF Pharma) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS).

Top news of the week from Specialty Pharmacy Times.

The years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.

The FDA has approved riluzole (Tigultik, ITF Pharma) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS).

The American Society of Health-System Pharmacists said it will offer instruction to pharmacists who are practicing or have trained outside the United States.

The approval of riluzole oral suspension fills a therapeutic need for patients with amyotrophic lateral sclerosis who develop swallowing impairment.

Hub services act to simplify the complexity and perform as an intermediary between involved parties.

The US Food and Drug Administration (FDA) has approved the first generic medication indicated for lowering the risk of heart attack, or death from heart attack or stroke in patients with acute coronary syndrome (ACS).

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection.

Through their Medicaid and Ryan White HIV/AIDS Programs, states play an integral role in ensuring access to care for people living with HIV.

Study provides insight into how cannabidiol acts in the brain to reduce psychotic symptoms.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.